[June 29, 2011]

Research and Markets: A Hepatitis C Global Clinical Trials Review for Q2, 2011 - Providing Comprehensive Data on Clinical Trials Globally

Research and Markets (http://www.researchandmarkets.com/research/68a43d/hepatitis_c_global) has announced the addition of GlobalData 's new report "Hepatitis C Global Clinical Trials Review, Q2, 2011" to their offering.

GlobalData's clinical trial report, Hepatitis C Global Clinical Trials Review, Q2, 2011 provides data on the Hepatitis C clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatitis C. It includes an overview of the trial numbers and their recruitmnt status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatitis C. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope:

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Key Topics Covered:

• Report Guidance
• Clinical Trials by Region
• Clinical Trials by Country
• Clinical Trials by BRIC Nations
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Unaccomplished Trials of Hepatitis C
• Subjects Recruited Over a Period of Time

Companies Mentioned Include:

• Abbott Laboratories
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Hoffmann-La Roche Inc.
• Human Genome Sciences, Inc.
• Idenix Pharmaceuticals, Inc.
• Johnson & Johnson
• Merck & Co., Inc.
• Mitsubishi (News - Alert) Tanabe Pharma Corporation
• Novartis AG
• Pfizer Inc.
• Romark Laboratories, L.C.
• SciClone Pharmaceuticals, Inc.
• Tibotec Pharmaceuticals Ltd.
• UMC Utrecht
• Valeant Pharmaceuticals International, Inc.
• Vertex (News - Alert) Pharmaceuticals Incorporated

For more information visit http://www.researchandmarkets.com/research/68a43d/hepatitis_c_global

[ Back To TMCnet.com's Homepage ]